WHO says approval of Russia’s Sputnik V vaccine ‘still pending’ Coronavirus epidemic news

Russia’s Sputnik V-Covid vaccine is stuck with missing data and legal proceedings, the UN agency says.

The World Health Organization (WHO) says Russia’s Sputnik V-Covid-1 vaccine has been put on hold due to a lack of information and legal action, which the UN hopes will be “resolved soon”.

“We are working almost every day with the Russian Ministry of Health to address the remaining issues covered by the Russian Direct Investment Fund,” said Marianzella Simao, WHO Assistant Director General for Access to Medicines and Health Products. Wednesday.

Simao said that as soon as an agreement is reached, the WHO will reopen the case and evaluate the submitted data, although it is “still incomplete” and will resume inspection of production sites in Russia.

“All the submissions we have have been resolved in the same way,” he said and did not set a deadline for when the listing process could be completed.

Members of the medical staff walk past an ambulance at a hospital for Kovid-1 infected patients in Komunarka outside Moscow. [Alexander Nemenov/AFP]

Russian Health Minister Mikhail Murashko said earlier this month that all barriers to vaccine registration with the WHO had been removed and only some paperwork remained to be completed.

Vaccine adoption in Russia has been slow, citing mistrust of authorities and fears of new medical products. In Russia, only 33 percent are fully vaccinated.

Russian President Vladimir Putin said Tuesday that Russia needs to step up its vaccination campaign against Kovid-1 because the country recorded a coronavirus-related death on Tuesday, the highest one-day death since the epidemic began.

In total, Russia has recorded more than 7.7 million cases and more than 426,000 deaths.

Sputnik light vaccine

Meanwhile, the Russian Direct Investment Fund (RDIF) said on Wednesday that the one-shot Sputnik Light vaccine, citing its developer, showed 70 percent effectiveness against the coronavirus delta variant three months after injection,

The developer, Gamalia Institute, submitted the pre-print server to medRxiv prior to the peer review and based on 28,000 participants who received a dose of Sputnik light, compared to a control group of 5.6 million individuals who were not vaccinated, it said.

Countries around the world are deploying or considering a third dose of Pfizer or modern vaccines or booster shots for some of their populations, especially those with weakened immune systems and the elderly, although there is no shortage of scientists on how widely they should be used.

Sputnik Light will be almost as effective as the Russian flagship two-shot Sputnik V vaccine against the Delta variant as a booster of other vaccines, RDIF, which markets Sputnik V internationally, said in a statement.

According to the RDIF, Sputnik Light will be effective against more than 3 per cent against infections and more than 4 per cent against hospitalization.

RDIF chief Kirill Dimitriev told Reuters he hoped Sputnik Light would eventually become Russia’s main vaccine against Kovid-1.

“Finally, we believe that Sputnik Light could be the main vaccine a year from now when many people will need to be re-vaccinated or will be covid and Sputnik V will not be needed,” Dimitriev said.

Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button